is semaglutide on the shortage list Ending: What's Next For Compounded Drugs? Addressing the Weight Loss Injectable

Eli Lilly & Company (US) Founded in 1876, Eli Lilly is a key innovator in metabolic health, contributing significantly to the evolution of GLP-1 receptor agonists and incretin-based therapies

Individuals with aldehyde dehydrogenase 2 (ALDH2) deficiency, most prevalent in East Asian populations, accumulate acetaldehyde during alcohol metabolism, producing severe flushing, tachycardia, and nausea even at low intake levels

Plaintiff lawyers say that gastroparesis and other bowel injuries are unwarned consequences of the use of Ozempic and similar drugs

As dosing becomes simpler, more patients may consider treatment earlier in their weight management journey